Muscle differentiation: More complexity to the network of myogenic regulators

Current Opinion in Genetics and Development

Volumn 8, Issue 5, 1998, Pages 539-544

  Arnold, Hans Henning ^a   Winter, Barbara ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MYOD PROTEIN; TRANSCRIPTION FACTOR;

CELL LINEAGE; CONTROL SYSTEM; COOPERATION; GENE DISRUPTION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; VERTEBRATE;

MAMMALIA; VERTEBRATA;

EID: 0032191350     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80008-7     Document Type: Article

References (51)

1. Arnold HH, Braun T. Targeted inactivation of myogenic factor genes reveals their roles during myogenesis: a review. Int Dev Biol. 40:1996;345-363.
2. Molkentin JD, Olson EN. Defining the regulatory networks for muscle development. Curr Opin Genet Dev. 6:1996;445-453.
3. Yun KS, Wold BJ. Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr Opin Cell Biol. 8:1996;877-889.
4. Cossu G, Kelly R, Tajbakhsh S, DiDonna S, Vivarelli E, Buckingham M. Activation of different myogenic pathways: Myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. Development. 122:1996;429-437.
5. Tajbakhsh S, Rocancourt D, Buckingham M. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature. 384:1996;266-270.
6. Hasty P, Bradley A, Morris JH, Edmondson DE, Venuti JM, Olson EN, Klein WH. Muscle deficiency and neonatal death in mice with targeted mutation in the myogenin gene. Nature. 364:1993;501-506.
7. Nabeshima YK, Hanaoka K, Hayasaka M, Esumi S, Lis, Nonaka J. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:1993;532-535.
8. Braun T, Arnold HH. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J. 14:1995;1176-1186.
9. Patapoutian A, Yoon K, Miner H, Wang S, Stark K, Wold B. Disruption of the MRF4 gene identifies multiple waves of myogenesis in the myotome. Development. 12:1995;3347-3358.
10. Zhang W, Behringer RR, Olson EN. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev. 9:1995;1388-1399.
11. Rawls A, Morris JH, Rudnicki M, Braun T, Arnold HH, Klein WH, Olson EN. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis. Dev Biol. 172:1995;37-50.
12. Wang Y, Schnegelsberg P, Dausman J, Jaenisch R. Functional redundancy of muscle-specific transcription factors Myf5 and myogenin. Nature. 379:1996;823-825.
13. Wang Y, Jaenisch R. Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. of special interest Development. 124:1997;2510-2513 The first knock-in experiment replacing one myogenic bHLH factor gene by another addresses the issue of unique intrinsic properties of Myf-5 and myogenin versus functional differences as a result of their distinct expression patterns. The results reveal that myogenin expressed under the control of the Myf-5 gene can partially substitute for Myf-5 but is unable to compensate for loss of a second myogenic bHLH gene in double mutants also lacking either MyoD or myogenin. This suggests that myogenin only inefficiently compensates for Myf-5, probably owing to altered levels of gene expression and/or different transactivation properties.
14. Gerber AN, Klesert TR, Bergstrom DA, Tapscott SJ. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. of special interest Genes Dev. 11:1997;436-450 This study provides evidence that MyoD and Myf-5 can remodel chromatin at binding sites in muscle gene enhancers and activate transcription at previously silent loci, whereas myogenin is markedly less efficient at activating genes in transcriptionally silent chromatin. The ability of MyoD to activate endogenous genes is associated with two regions in the protein that are distinct from its transactivation domain and are conserved in the Myf-5 protein, TGF-β, basic FGF, and sodium butyrate - known inhibitors of myogenesis - block MyoD-mediated chromatin reorganization. These results may provide a molecular basis for the fact that MyoD and Myf-5 establish the myogenic lineage, whereas myogenin mediates terminal differentiation.
15. Zhu Z, Miller JB. MRF4 can substitute for myogenin during early stages of myogenesis. Dev Dyn. 209:1997;233-241.
16. Rawls A, Valdez MR, Zhang W, Richardson J, Klein WH, Olson EN. Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. of special interest Development. 125:1998;2349-2358 Circumstantial evidence had suggested that MRF4 may fulfil late functions in muscle differentiation, similar to and possibly overlapping with myogenin. Double mutant mice for MRF4 and myogenin now show that neither gene is absolutely essential for myoblast differentiation; instead, any of the four myogenic bHLH factors appears capable of activating the muscle differentiation program under the appropriate conditions. Unexpectedly, MRF4/MyoD double mutants reveal overlapping roles of both genes in the control of myoblast differentiation, as the mutants lack differentiated myotubes. As Myf-5 and myogenin are expressed in these mutants, the observations suggest that critical threshold concentrations of myogenic bHLH factors may be needed for myoblast differentiation to occur.
17. Münsterberg AE, Kitajewski J, Bumcrot DA, McMahon AP, Lassar AB. Combinatorial signaling by sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in somites. Genes Dev. 9:1995;2911-2922.
18. Stern HM, Brown AMC, Hauschka SD. Myogenesis in paraxial mesoderm: Preferential induction by dorsal neural tube and by cells expressing Wnt-1. Development. 121:1995;3675-3686.
19. Spence MS, Yip J, Erickson CA. The dorsal neural tube organizes the dermamyotome and induces axial myocytes in the avian embryo. Development. 122:1996;231-241.
20. Reshef R, Maroto M, Lassar AB. Regulation of dorsal somitic cell fates: BMPs and Noggin control the timing and pattern of myogenic regulator expression. Genes Dev. 12:1998;290-303.
21. Cheng TC, Wallace MC, Merlie JP, Olson EN. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science. 261:1993;215-218.
22. Yee SP, Rigby PW. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7:1993;1277-1289.
23. Buchberger A, Ragge K, Arnold HH. The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF2. J Biol Chem. 286:1994;17289-17296.
24. Naidu PS, Ludolph DC, To RR, Hinterberger TJ, Konieczny SF. Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis. Mol Cell Biol. 15:1995;2707-2718.
25. Black BL, Martin JF, Olson EN. The mouse MRF4 promoter is transactivated directly and indirectly by muscle-specific transcription factors. J Biol Chem. 270:1995;2889-2892.
26. Pin CL, Ludolph DC, Cooper ST, Klocke BJ, Merlie JP, Konieczny SF. Distal regulatory elements control MRF4 gene expression in early and late myogenic cell populations. Dev Dyn. 208:1997;299-312.
27. Patapoutian A, Miner H, Lyons GE, Wold B. Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice. Development. 118:1993;61-69.
28. Zweigerdt R, Braun T, Arnold HH. Faithful expression of the Myf-5 gene during mouse myogenesis requires distant control regions: a transgene approach using yeast artificial chromosomes. Dev Biol. 191:1997;172-180.
29. Daston G, Lamar E, Olivier M, Goulding M. Pax 3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development. 122:1996;1017-1027.
30. Bober E, Franz T, Arnold HH, Gruss P, Trambley P. Pax 3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development. 120:1994;603-612.
31. Tajbakhsh S, Rocancourt D, Cossu G, Buckingham M. Redefining the genetic hierarchies controlling skeletal myogeneis: pax 3 and myf5 act upstream of myoD. of outstanding interest Cell. 89:1997;127-138 This paper establishes Pax3 as a key regulator in skeletal muscle development. By a genetic approach, the authors demonstrate that MyoD gene activation in body muscle precursors is dependent on either Pax3 or Myf-5. In Pax3/Myf-5 double homozygous mutant mice, MyoD is not expressed and body muscles are completely absent. Thus, Pax3 and Myf-5 define two distinct myogenic pathways and both genes act genetically upstream of MyoD. This hierarchy, however, does not apply to head muscle formation.
32. Maroto M, Reshef R, Münsterberg AE, Koester S, Goulding M, Lassar AB. Ectopic pax3 activates myoD and myf5 expression in embryonic mesoderm and neural tissue. of outstanding interest Cell. 89:1997;139-148 The study demonstrates that signals from ectoderm or Wnt and Sonic hedgehog can induce dermomyotomal and myotomal markers in presegmented mesoderm. Pax3 and Pax7 are induced concomitantly with Myf-5 and prior to MyoD. Moreover, retroviral expression of Pax3 in embryonic tissues, such as paraxial and lateral plate mesoderm as well as neural tube explants induces MyoD expression and myogenesis in the absence of inducing signals. These results imply that Pax3 mediates activation of Myf-5 and MyoD expression in response to muscle-inducing signals.
33. Rawls JA, Parsons S, Wilson-Rawls NJ. Mice lacking paraxis and Myf-5 display severe defects in skeletal muscle and axial skeleton. Dev Biol. 198:1998;217.
34. Olson EN, Perry M, Schulz RA. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol. 172:1995;2-14.
35. Bour BA, O'Brien MA, Lockwood WL, Goldstein ES, Bodmer R, Taghert PH, Abmayr SM, Nguyen HT. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9:1995;730-741.
36. Lilly B, Zhao B, Ranganayakulu G, Paterson BM, Schulz RA, Olson EN. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science. 267:1995;688-693.
37. Ranganayakulu G, Zhao B, Dokodis A, Molkentin JD, Olson EN, Schulz RA. A series of mutations in the D-MEF2 transcription factor reveals multiple functions in larval and adult myogenesis in Drosophila. Dev Biol. 171:1995;169-181.
38. Lin Q, Schwarz JJ, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by the myogenic transcription factor MEF2C. Science. 278:1997;1404-1407.
39. Molkentin JD, Black BL, Martin JF, Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1995;1125-1136.
40. Black BL, Molkentin JD, Olson EN. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. of special interest Mol Cell Biol. 18:1998;69-77 Synergistic activation of muscle-specific transcription by myogenic bHLH and MEF2 transcription factors occurs through interaction between these proteins and binding of the complex to either bHLH or MEF2 DNA target sites. The ability of these proteins to synergistically initiate myogenesis is dependent on two conserved animo acid residues: alanine and threonine in the basic domain of the myogenic bHLH factors. The paper now demonstrates that these two 'myogenic' amino acids are not required to form complexes between bHLH proteins and MEF2 factors but to acquire the transactivation competence provided either from the MyoD or MEF2 transactivation domain. Thus, MEF2 may be the putative myogenic cofactor which allows transmission of transcriptional activation signals, possibly by inducing a compatible conformation for interaction with the basal transcription machinery or other cofactors. The dependence on the basic domain of MyoD (alanine and threonine) can be bypassed by substitution of the MyoD or the MEF2 activation domain with the activation domain of VP16. As myogenic bHLH-MEF2 interactions can be uncoupled from transcriptional activation, the results support the idea that the myogenic amino acids in myogenic bHLH proteins are essential for generating the transactivation capacity.
41. Sartorelli V, Huang J, Hamamori Y, Kedes L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol. 17:1997;1010-1026.
42. Arber S, Halder G, Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell. 79:1994;221-231.
43. Kong Y, Flick MJ, Kudla AJ, Konieczny SF. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol Cell Biol. 17:1997;4750-4760.
44. Stern HM, Lin-Jones J, Hauschka SD. Synergistic interactions between bFGF and a TGF-beta family member may mediate myogenic signals from the neural tube. Development. 124:1997;3511-3523.
45. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 387:1997;83-90.
46. Langlands K, Yin X, Anand G, Prochownik EV. Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J Biol Chem. 272:1997;19785-19793.
47. Spicer DB, Rhee SJ, Cheung WL, Lassar AB. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science. 272:1996;1476-1480.
48. Hamamori Y, Wu HY, Sartorelli V, Kedes L. The basic domain of myogenic bHLH proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol. 17:1997;6563-6573.
49. Lemercier C, To RQ, Carrasco RA, Konieczny SF. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of MyoD. EMBO J. 17:1998;1412-1422.
50. Chen CM, Kraut N, Groudine M, Weintraub H. I-mf, a novel myogenic repressor interacts with members of the MyoD family. Cell. 86:1996;731-741.
51. Postigo AA, Dean DC. ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. EMBO J. 16:1997;3935-3943.